Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion

The ectonucleotidases CD39 and CD73 degrade ATP to adenosine which inhibits immune responses via the A(2A) adenosine receptor (ADORA2A) on T and NK cells. The current study investigates the potential therapeutic use of the specific anti CD39- and anti CD73-antibodies A1 (CD39) and 7G2 (CD73) as thes...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Häusler, Sebastian FM, del Barrio, Itsaso Montalbán, Diessner, Joachim, Stein, Roland G, Strohschein, Jenny, Hönig, Arnd, Dietl, Johannes, Wischhusen, Jörg
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2014
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902223/
https://ncbi.nlm.nih.gov/pubmed/24489992
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares